Increased BDNF levels in long-term bipolar disorder patients

AUTOR(ES)

Barbosa, Izabela Guimarães, Rocha, Natália Pessoa, Miranda, Aline Silva de, Huguet, Rodrigo Barreto, Bauer, Moisés Evandro, Reis, Helton José, Teixeira, Antônio Lúcio

FONTE

Rev. Bras. Psiquiatr.

DATA DE PUBLICAÇÃO

2013-03

RESUMO

INTRODUCTION: Bipolar disorder (BD) is a prevalent, chronic and progressive illness. There is a growing body of evidence indicating that brain-derived neurotrophic factor (BDNF) plays an important role in the pathophysiology of BD. OBJECTIVE: The aim of this study was to evaluate BDNF plasma levels in BD patients with long term illness in comparison with controls. METHODS: 87 BD type I patients and 58 controls matched by age, gender and education level were enrolled in this study. All subjects were assessed by the Mini-International Neuropsychiatric Interview and the patients by the Young Mania Rating Scale and the Hamilton Depression Rating Scale. The plasma levels of BDNF were measured by ELISA. RESULTS: On average, patients had suffered from BD for 23.4 years. In comparison with controls, BD patients with mania presented a 1.90-fold increase in BDNF plasma levels (p = .001), while BD patients in remission presented a 1.64-fold increase in BDNF plasma levels (p = .03). BDNF plasma levels were not influenced by age, length of illness or current medications. CONCLUSIONS: The present study suggests that long-term BD patients exhibit increased circulating levels of BDNF.

Documentos Relacionados

• Deaths in long-term paced patients.
• Ciclesonide as a manic trigger in a patient with long-term stable bipolar disorder: a case report
• Serum BDNF levels in unaffected first-degree relatives of patients with bipolar disorder
• Long-term potentiation and long-term depression: a clinical perspective
• Endogenous BDNF is required for long-term memory formation in the rat parietal cortex